Breast Cancer and Oestrogen Receptor mRNA Levels
Author Information
Author(s): J.A. Henry, S. Nicholson, C. Hennessy, T.W.J. Lennard, F.E.B. May, B.R. Westley
Primary Institution: University of Newcastle upon Tyne
Hypothesis
The expression of pNR-2 mRNA in breast cancer is related to oestrogen receptor mRNA levels and response to tamoxifen therapy.
Conclusion
The study found that pNR-2 mRNA levels are associated with response to tamoxifen therapy in breast cancer patients.
Supporting Evidence
- 90% of primary breast tumours not receiving endocrine therapy expressed oestrogen receptor mRNA.
- 57% of primary breast tumours expressed pNR-2 mRNA.
- pNR-2 mRNA levels were significantly correlated with oestrogen receptor mRNA levels in primary tumours.
Takeaway
This study looked at breast cancer samples to see how a specific RNA, pNR-2, is related to another RNA that helps doctors understand how well a treatment called tamoxifen might work.
Methodology
The study measured pNR-2 and oestrogen receptor mRNA levels in 96 breast tumour samples using RNA extraction and hybridisation techniques.
Limitations
The study does not account for all factors influencing pNR-2 expression and its relationship with treatment response.
Participant Demographics
The study included 96 breast cancer patients, with a mix of pre- and post-menopausal women.
Statistical Information
P-Value
P<0.025
Statistical Significance
p<0.025
Want to read the original?
Access the complete publication on the publisher's website